History and Milestones
Forus Health was established in 2010 by with a vision to connect innovation and technology to empower healthcare providers and ensure quality eye care is accessible, affordable, and inclusive for all.
Early Inspiration and Foundation
The founders recognized a critical gap in early diagnosis and treatment of preventable blindness
in India. Driven by the transformative potential of innovation and technology, they established
Forus Health to create affordable diagnostic solutions that empower healthcare providers and
bring quality eye care to all.
Key Milestones and Progression
2010
Forus Health was founded in Bangalore, India, with the vision of addressing the global challenge of visual impairment and blindness by making eye care accessible, affordable, and impactful for all.
The company’s name, ‘Forus,’ signifies its commitment to ‘FOR the USers.’
Forus Health launches 3nethra classic, a comprehensive eye screening platform designed to detect major conditions such as cataracts, diabetic retinopathy, glaucoma, and corneal issues
The First 3nethra classic was handed over to Aravind Eye Hospital.
2012-2013
Forus Health introduces the 3nethra royal, a cutting-edge solution for eye care.
Forus Health raises $5 million in funding from Accel Partners and IDG Ventures to
fuel its growth.
Forus Health secures $8.1 million in funding from Accel Partners, IDG Ventures,
and Asian Health Fund to drive innovation.
Forus Health launches cloud-based telemedicine features to support remote
diagnosis and consultations.
Forus Health is recognized for its affordability, portability, and ease of use,
making it a suitable choice for rural and remote areas
2014–2015
Forus Health Introduces CDSS for Diabetic Retinopathy, Glaucoma, and Corneal Opacity
Forus Health launches 3nethra flora, a digital mydriatic fundus camera offering high-contrast, undistorted retinal images for accurate diagnoses
Forus Health expands global presence, highlighting the international relevance of its solutions
Forus Health launches cloud-based telemedicine features for remote diagnosis and consultations
2016 - 2017
Forus Health launches one of the largest tele-ophthalmology programs in
partnership with Apollo Telehealth, enhancing accessibility, especially in remote
areas
Forus Health prioritizes collaboration with healthcare providers &
governments, driving innovations that scale access to eye care globally &
deliver impactful solutions.
Forus Health launches 3nethra neo, a portable retinal imaging device specifically
designed for the early detection of Retinopathy of Prematurity (ROP) in
newborns and premature babies.
Forus Health opens its new office in the United States, marking a significant
milestone in expanding global presence and commitment to providing innovative
healthcare solutions worldwide
2018–2019
Forus Health successfully raises Series C funding from AHF, Accel Partners, and Teamfund, marking a significant milestone in the growth journey.
Forus Health launches the hand-held, AI-powered 3nethra aberro for refraction measurement at home and 3nethra classic HD, which integrates lipid layer interferometry for assessing tear film stability, along with high-definition (HD) imaging capabilities that deliver higher resolution and more detailed images.
Forus expanded its product portfolio to address systemic diseases through ocular biomarkers, aligning with the concept of ‘the eye as a window to overall health.
Forus Health launches its digital health platform, FH TeleCare, a cloud-based solution designed to enhance access to healthcare services by enabling remote diagnostics through AI-driven solutions and portable devices.
2020 – 2021
Forus Health raises Series D funding from Teamfund to support the continued
development and expansion of its healthcare solutions
Forus Health advances with the adoption of artificial intelligence (AI) and
machine learning, enhancing its diagnostic capabilities for more accurate and
efficient healthcare solutions
Forus Health introduces the 3nethra classic 6.4, a portable retinal screening
device designed to enhance early detection of eye diseases with ease of use and
accessibility in remote areas
Forus Health launches the 3nethra specto, a groundbreaking device enabling
remote retinal screening without the need for an optometrist
Forus Health introduces the FH-TeleEye app, enabling remote eye screenings
with portable retinal cameras and AI-driven insights for accurate diagnoses of
conditions like Retinopathy of Prematurity, enhancing access to quality eye care
in remote areas
Forus Health launches the 3nethra neo HD, a portable retinal imaging device
designed for accurate and efficient screening of Retinopathy of Prematurity
(ROP) and other eye conditions in newborns, providing high-definition images
and AI-driven analysis to enhance early diagnosis and improve access to quality
eye care
2023 – 2024
Forus Health unveils FH-POISE (Platform for Ocular Intelligence for Systemic and
Eye Diseases), an AI-powered platform that combines ocular imaging and
artificial intelligence to enhance early detection and predictive healthcare,
improving patient outcomes through insights into both eye and systemic health.
Forus Health introduces the 3nethra specto in the US, a groundbreaking
wearable optometry device in the new ‘WearOpter’ category, pioneering Digital
Optometry as a Service (DoaaS). It provides fast, accurate vision assessments and
enables remote early detection, significantly improving access to eye care and
patient outcomes.
Forus Health launches 3nethra pico for retinal imaging in home settings
2025
Forus Health marks its 15th anniversary, reflecting on years of progress in
advancing healthcare solutions.
2010
Forus Health was founded in Bangalore, India, with the vision of addressing the global challenge of visual impairment and blindness by making eye care accessible, affordable, and impactful for all.
The company’s name, ‘Forus,’ signifies its commitment to ‘FOR the USers.’
Forus Health launches 3nethra classic, a comprehensive eye screening platform designed to detect major conditions such as cataracts, diabetic retinopathy, glaucoma, and corneal issues
The First 3nethra classic was handed over to Aravind Eye Hospital.
2012-2013
Forus Health introduces the 3nethra royal, a cutting-edge solution for eye care.
Forus Health raises $5 million in funding from Accel Partners and IDG Ventures to
fuel its growth.
Forus Health secures $8.1 million in funding from Accel Partners, IDG Ventures,
and Asian Health Fund to drive innovation.
Forus Health launches cloud-based telemedicine features to support remote
diagnosis and consultations.
Forus Health is recognized for its affordability, portability, and ease of use,
making it a suitable choice for rural and remote areas
2014–2015
Forus Health Introduces CDSS for Diabetic Retinopathy, Glaucoma, and Corneal
Opacity
Forus Health launches 3nethra flora, a digital mydriatic fundus camera offering
high-contrast, undistorted retinal images for accurate diagnoses
Forus Health expands global presence, highlighting the international relevance of
its solutions
Forus Health launches cloud-based telemedicine features for remote diagnosis
and consultations
2016 - 2017
Forus Health launches one of the largest tele-ophthalmology programs in
partnership with Apollo Telehealth, enhancing accessibility, especially in remote
areas
Forus Health prioritizes collaboration with healthcare providers &
governments, driving innovations that scale access to eye care globally &
deliver impactful solutions.
Forus Health launches 3nethra neo, a portable retinal imaging device specifically
designed for the early detection of Retinopathy of Prematurity (ROP) in
newborns and premature babies.
Forus Health opens its new office in the United States, marking a significant
milestone in expanding global presence and commitment to providing innovative
healthcare solutions worldwide
2018–2019
Forus Health successfully raises Series C funding from AHF, Accel Partners, and
Teamfund, marking a significant milestone in the growth journey.
Forus Health launches the hand-held, AI-powered 3nethra aberro for refraction
measurement at home and 3nethra classic HD, which integrates lipid layer
interferometry for assessing tear film stability, along with high-definition (HD)
imaging capabilities that deliver higher resolution and more detailed images.
Forus expanded its product portfolio to address systemic diseases through ocular
biomarkers, aligning with the concept of ‘the eye as a window to overall health.
Forus Health launches its digital health platform, FH TeleCare, a cloud-based
solution designed to enhance access to healthcare services by enabling remote
diagnostics through AI-driven solutions and portable devices.
2020 – 2021
Forus Health raises Series D funding from Teamfund to support the continued
development and expansion of its healthcare solutions
Forus Health advances with the adoption of artificial intelligence (AI) and
machine learning, enhancing its diagnostic capabilities for more accurate and
efficient healthcare solutions
Forus Health introduces the 3nethra classic 6.4, a portable retinal screening
device designed to enhance early detection of eye diseases with ease of use and
accessibility in remote areas
Forus Health launches the 3nethra specto, a groundbreaking device enabling
remote retinal screening without the need for an optometrist
Forus Health introduces the FH-TeleEye app, enabling remote eye screenings
with portable retinal cameras and AI-driven insights for accurate diagnoses of
conditions like Retinopathy of Prematurity, enhancing access to quality eye care
in remote areas
Forus Health launches the 3nethra neo HD, a portable retinal imaging device
designed for accurate and efficient screening of Retinopathy of Prematurity
(ROP) and other eye conditions in newborns, providing high-definition images
and AI-driven analysis to enhance early diagnosis and improve access to quality
eye care
2023 – 2024
Forus Health unveils FH-POISE (Platform for Ocular Intelligence for Systemic and
Eye Diseases), an AI-powered platform that combines ocular imaging and
artificial intelligence to enhance early detection and predictive healthcare,
improving patient outcomes through insights into both eye and systemic health.
Forus Health introduces the 3nethra specto in the US, a groundbreaking
wearable optometry device in the new ‘WearOpter’ category, pioneering Digital
Optometry as a Service (DoaaS). It provides fast, accurate vision assessments and
enables remote early detection, significantly improving access to eye care and
patient outcomes.
Forus Health launches 3nethra pico for retinal imaging in home settings
2025
Forus Health marks its 15th anniversary, reflecting on years of progress in
advancing healthcare solutions.
